HK-listed Luye Pharma may secure up to $220m from China's state-owned fund manager

Retrieved on: 2024-07-23 17:13:42

Tags for this article:

Click the tags to see associated articles and topics

HK-listed Luye Pharma may secure up to $220m from China's state-owned fund manager. View article details on hiswai:

Excerpt

The proceeds will be used to accelerate the development of Hong Kong-listed Luye Pharma Group's oncology drug business.

Article found on: www.dealstreetasia.com